131 related articles for article (PubMed ID: 38736379)
1. Pluronic P123/DMSO Lyotropic Liquid Crystal for Incorporating Bioactive Substances for Topical Application.
Selivanova NM; Galeeva AI; Ziganshin MA; Galyametdinov YG
J Phys Chem B; 2024 May; 128(20):5127-5134. PubMed ID: 38736379
[TBL] [Abstract][Full Text] [Related]
2. Reverse lyotropic liquid crystals from europium nitrate and P123 with enhanced luminescence efficiency.
Yi S; Li Q; Liu H; Chen X
J Phys Chem B; 2014 Oct; 118(39):11581-90. PubMed ID: 25215923
[TBL] [Abstract][Full Text] [Related]
3. Chitosan/Lactic Acid Systems: Liquid Crystalline Behavior, Rheological Properties, and Riboflavin Release In Vitro.
Selivanova NM; Galeeva AI; Galyametdinov YG
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362002
[TBL] [Abstract][Full Text] [Related]
4. Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.
Rajabalaya R; Musa MN; Kifli N; David SR
Drug Des Devel Ther; 2017; 11():393-406. PubMed ID: 28243062
[TBL] [Abstract][Full Text] [Related]
5. On the Structure and Transdermal Profile of Liquid Crystals Based on Phytantriol.
Chu XQ; Huang J; Li ZG; Li Q; Cao JJ; Jiang JQ; Gui SY
Curr Drug Deliv; 2018; 15(10):1439-1448. PubMed ID: 30198435
[TBL] [Abstract][Full Text] [Related]
6. Role of molecular weight and hydrophobicity of amphiphilic tri-block copolymers in temperature-dependent co-micellization process and drug solubility.
Lee CF; Yang CH; Lin TL; Bahadur P; Chen LJ
Colloids Surf B Biointerfaces; 2019 Nov; 183():110461. PubMed ID: 31479972
[TBL] [Abstract][Full Text] [Related]
7. Phase transition and release kinetics of polyphenols encapsulated lyotropic liquid crystals.
Zhang H; Wang Z
Int J Pharm; 2019 Jun; 565():283-293. PubMed ID: 31078646
[TBL] [Abstract][Full Text] [Related]
8. Advances in lyotropic liquid crystal systems for skin drug delivery.
Silvestrini AVP; Caron AL; Viegas J; Praça FG; Bentley MVLB
Expert Opin Drug Deliv; 2020 Dec; 17(12):1781-1805. PubMed ID: 32886531
[TBL] [Abstract][Full Text] [Related]
9. Graphene quantum dot doped viscoelastic lyotropic liquid crystal nanocolloids for antibacterial applications.
Singh P; Farheen ; Sachdev S; Manori S; Bhardwaj S; Chitme H; Sharma A; Raina KK; Shukla RK
Soft Matter; 2023 Aug; 19(34):6589-6603. PubMed ID: 37605525
[TBL] [Abstract][Full Text] [Related]
10. Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications.
Libster D; Aserin A; Garti N
J Colloid Interface Sci; 2011 Apr; 356(2):375-86. PubMed ID: 21315366
[TBL] [Abstract][Full Text] [Related]
11. Lyotropic liquid crystal-based transcutaneous peptide delivery system: Evaluation of skin permeability and potential for transcutaneous vaccination.
Kozaka S; Wakabayashi R; Kamiya N; Goto M
Acta Biomater; 2022 Jan; 138():273-284. PubMed ID: 34774785
[TBL] [Abstract][Full Text] [Related]
12. Lyotropic liquid crystal elastomers for drug delivery.
Stepulane A; Ahlgren K; Rodriguez-Palomo A; Rajasekharan AK; Andersson M
Colloids Surf B Biointerfaces; 2023 Jun; 226():113304. PubMed ID: 37062225
[TBL] [Abstract][Full Text] [Related]
13. Enhancing thermal stability and mechanical properties of lyotropic liquid crystals through incorporation of a polymerizable surfactant.
Peng S; Hartley PG; Hughes TC; Guo Q
Soft Matter; 2015 Aug; 11(31):6318-26. PubMed ID: 26166631
[TBL] [Abstract][Full Text] [Related]
14. Oral Drug Delivery via Intestinal Lymphatic Transport Utilizing Lipid-Based Lyotropic Liquid Crystals.
Dinh L; Yan B
Liquids (Basel); 2023 Dec; 3(4):456-468. PubMed ID: 38711572
[TBL] [Abstract][Full Text] [Related]
15. Pluronic 123 Liquid Lyotropic Crystals for Transdermal Delivery of Caffeic Acid-Insights from Structural Studies and Drug Release.
Romeo M; Mazzotta E; Lovati F; Porto M; Rossi CO; Muzzalupo R
Gels; 2024 Mar; 10(3):. PubMed ID: 38534599
[TBL] [Abstract][Full Text] [Related]
16. Self-assembling in situ gel based on lyotropic liquid crystals containing VEGF for tissue regeneration.
Wang B; Huang Y; Huang Z; Wang H; Chen J; Pan X; Wu C
Acta Biomater; 2019 Nov; 99():84-99. PubMed ID: 31521813
[TBL] [Abstract][Full Text] [Related]
17. Formulation and characterization of liquid crystal systems containing azelaic acid for topical delivery.
Aytekin M; Gursoy RN; Ide S; Soylu EH; Hekimoglu S
Drug Dev Ind Pharm; 2013 Feb; 39(2):228-39. PubMed ID: 22480294
[TBL] [Abstract][Full Text] [Related]
18. Cilostazol-loaded electrospun three-dimensional systems for potential cardiovascular application: Effect of fibers hydrophilization on drug release, and cytocompatibility.
Rychter M; Milanowski B; Grześkowiak BF; Jarek M; Kempiński M; Coy EL; Borysiak S; Baranowska-Korczyc A; Lulek J
J Colloid Interface Sci; 2019 Feb; 536():310-327. PubMed ID: 30380431
[TBL] [Abstract][Full Text] [Related]
19.
Fan L; Song C; Lu X; Wang T; Han J; Guo R
Soft Matter; 2022 Oct; 18(40):7859-7865. PubMed ID: 36200686
[TBL] [Abstract][Full Text] [Related]
20. Shear rheology and in-vitro release kinetic study of apigenin from lyotropic liquid crystal.
Fan J; Liu F; Wang Z
Int J Pharm; 2016 Jan; 497(1-2):248-54. PubMed ID: 26657272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
